ADIPOCYTES ARE ONE OF THE major cellular sites for energy storage in the body through lipogenic and lipolytic regulation processes. They also play an important role in energy homeostasis by modulating thermogenesis. Indeed, adipocytes from brown adipose tissue, mainly developed in rodents, express the mitochondrial uncoupling protein (UCP)-1. UCP-1 is involved in heat production by uncoupling electron transport from the mitochondrial respiratory chain (28) . Recently, additional UCP-related genes have been identified. UCP-2 was found to be expressed in a wide range of cells and tissues, including white adipocytes, whereas UCP-3 expression was restricted mainly to skeletal and cardiac muscle (3, 11, 14, 29) . Although the function of both UCP-2 and -3 proteins has to be clearly established, several lines of evidence strongly suggest their involvement in the control of energy dissipation. For example, ectopic expression of UCP-2 and -3 in yeast has been shown to decrease the mitochondrial membrane potential associated with uncoupling of respiration (14, 15) .
Obesity is characterized by an imbalance between energy intake and expenditure. Alterations in the control of adipocyte lipogenic and/or lipolytic processes have been well documented in obesity and revealed, in most white adipose tissues (WAT) of obese people, a decreased catecholamine-induced lipolysis. The recent demonstration of a reduced expression of UCP-2 gene in WAT of obese people (26) has stressed the new concept of a potential impairment of adipocyte energy dissipation in obesity. The factors controlling UCP-2 expression in adipocytes remain to be well characterized. Changes in metabolism such as fat diet (24) and short-term fasting (2) have been shown to influence adipocyte UCP-2 expression and various adipocytederived cytokines. Among them, tumor necrosis factor-␣ (TNF-␣), which is produced in high amounts in human obesity (16, 18) , has been recently described to decrease the expression of UCP-2 in human explants of adipose tissue (30) . However, the mechanism of action of TNF-␣ involved in the alteration of UCP-2 expression in adipocytes has not been studied yet. TNF-␣ is known to induce the expression of the inducible (i) nitric oxide synthase (NOS) in various cell types and tissues (12) . The presence of iNOS protein has been demonstrated recently in adipocytes from rodents (27) and humans (1) and in 3T3-L1 differentiated adipocytes treated with a mixture of various cytokines and growth factors (17) . In the present study, we examined the effect of TNF-␣ on UCP-2 expression in differentiated 3T3F442A adipocytes, and we tested the hypoth-esis that the induction of iNOS could be involved in the control of UCP-2 expression by TNF-␣.
MATERIALS AND METHODS
Cell culture. 3T3F442A preadipocyte cells were grown as previously described (4) . Cells were cultured until confluence in a culture medium consisting of DMEM supplemented with 10% donor calf serum and an antibiotic mixture (500 U/ml penicillin and 50 g/ml streptomycin) in an atmosphere of 95% air-5% CO 2 at 37°C. At confluence, cells were differentiated by incubation in DMEM supplemented with 10% FCS and 50 nmol/l insulin. Ten days after confluence, cells were maintained for 12 h in a serum-deprived medium containing 0.1% BSA and were treated as described in RESULTS. After treatment, supernatants were collected for nitrite determination, and cells were stored at Ϫ80°C until analysis.
Measurements of nitrite production. Nitrite concentration was determined in cell supernatant by the Griess reagent [5.44% sulfanylamide; 0.5 mol/l HCl and 0.128% N-(1-naphthyl)ethylenediamine; or 0.5 mol/l HCl (1:1)]. After 10 min at room temperature, absorbance was read at 540 nm (iEMS Labsystem). The nitrite concentrations were calculated from a standard curve obtained with increasing concentrations of NaNO 2 (0-50 mol/l).
Western blot analysis. Cells were washed two times with PBS and scraped. After brief centrifugation (1,000 g, 2 min, 4°C), pellets were resuspended in 200 l of lysis buffer containing 10 mmol/l Tris ⅐ HCl (pH 7.5), 0.15 mol/l NaCl, 2 mmol/l sodium vanadate, 0.1% SDS, 1% Nonidet P-40, 1% sodium deoxycholate, 2 mmol/l phenylmethylsulfonyl fluoride, and a mix of protease inhibitors. The lysate was then centrifuged at 13,000 g for 30 min at 4°C, and protein concentrations of the supernatant were determined using a protein determination kit. Proteins (70 g) were separated by electrophoresis on 10% SDS-8% PAGE under denaturing conditions. After transfer to nitrocellulose membranes and Ponceau staining to verify equal loading of the lanes, membranes were blocked overnight in 50 mmol/l Tris ⅐ HCl, 200 mmol/l NaCl, 0.05% Tween 20, and 5% fat milk at 4°C and then were incubated with the primary antibody (mouse antiiNOS diluted 1:5,000) for 90 min followed by incubation with the secondary antibody (anti-mouse immunoglobulin conjugated with horseradish peroxidase diluted 1:7,500) for 60 min. The immunocomplexes were detected using a chemiluminescence reagent kit.
Extraction of RNA and Northern blot analysis. Total RNAs were extracted by the standard acid guanidium-phenol-chloroform method of Chomczynsky and Sacchi (6) and were dissolved in a solution containing 50% formamide, 3 mmol/l sodium acetate, 1 mmol/l EDTA, and 2.2 mol/l formaldehyde. Total RNA samples (20 g ) were heated at 65°C for 10 min, resuspended, and loaded on 1% denaturated agarose gel. After electrophoresis, RNAs were transferred to a nylon membrane for 1 h under vacuum (40 mbars for 90 min). The membrane was prehybridized for 1 h at 65°C in a buffer containing 0.5 mol/l NaHPO 4 , 1 mol/l EDTA, 7% SDS, and 1% BSA and was hybridized overnight with [ 32 P]UCP-2 probe at 65°C in the same buffer. Membranes were then washed two times in a twofold concentrated standard saline citrate (SSC; 0.15 mol/l NaCl and 15 mmol/l sodium citrate, pH 7.0) supplemented with 0.1% SDS at room temperature, two times in 0.2-fold concentrated SSC supplemented with 0.1% SDS at 50°C, and one time in 0.1-fold concentrated SSC supplemented with 0.1% SDS at 65°C. To confirm equal loading of the lanes, membranes were stripped and hybridized with a 32 P-labeled ␤-actin probe. After 24-h autoradiography at Ϫ80°C, the intensity of each band was quantified as integrated areas by using computerized densitometry (Molecular Dynamics, Sunnyvale, CA) and ImageQuant NT Software. Densitometric values were determined in areas of equal size and reported in arbitrary units above background values. The intensity of UCP-2 mRNA band was normalized for the ␤-actin signal in each lane.
Materials. Chemicals were purchased from Sigma (St. Louis, MO). DMEM and donor serum and FCS were obtained from Life Technology (Gaithersburg, MD). S-nitroso-L-glutathione (GSNO) was from Alexis Biochemicals. Mouse recombinant TNF-␣ was obtained from Sigma [lipopolysaccharide (LPS) Ͻ0.1 ng/g TNF-␣ as provided by the manufacturer]. Preliminary experiments were performed using mouse recombinant TNF-␣ (LPS level Ͻ0.1 ng/g TNF-␣ or 1 endotoxin unit/g as provided by the manufacturer) purchased by PeproTech (TEBU). Mouse anti-iNOS antibody was purchased from Transduction Laboratories (Lexington, KY), and anti-mouse IgG conjugated with horseradish peroxidase was from Calbiochem (La Jolla, CA). LPS from Salmonella typhimurium was obtained from Sigma. Plasmid containing the mouse UCP-2 cDNA was a generous gift from Dr. Daniel Riquier (Ceremod, Meudon, France). The radiolabeled EcoR I/Sac I 935 bp of the UCP-2 cDNA was used as a probe in the Northern blot experiments. Positive control for iNOS was prepared from the macrophage cell line RAW 264.7 (provided by Dr. Bernard Pipy) stimulated by TNF-␣ (10 ng/ml), interferon-␥ (IFN-␥; 10 ng/ml), and LPS from Escherichia coli (5 g/ml). The mix of proteases inhibitors was Complete mini tablets from Roche Diagnostics (Meylan, France). Protein concentrations were assessed by the Bio-Rad DC Protein kit (Bio-Rad, Ivry/Seine, France). Nitrocellulose and nylon membranes for Western and Northern blot analysis were purchased from Schleicher & Schuell (Dassel, Germany). The chemiluminescence reagent kit was the enhanced chemiluminescence kit from Amersham Life Science (Les Ulis, France).
Statistical analysis. Values are expressed as means Ϯ SE. Data were analyzed by an ANOVA followed by a Dunnett's multiple-comparison post hoc test.
RESULTS

Effect of TNF-␣ on UCP-2 mRNA expression.
Northern blot analyses were performed on total RNA extracts obtained from 10-day differentiated 3T3F442A adipocytes treated for 2, 8, 12, or 24 h with 10 ng/ml mouse recombinant TNF-␣. UCP-2 mRNA was normalized to ␤-actin expression.
As shown in Fig. 1 , short-term TNF-␣ stimulation on differentiated 3T3F442A cells (from 2 to 8 h) had no significant effect on UCP-2 transcript levels compared with unstimulated cells. TNF-␣ treatment for 12 h led to a significant decrease in UCP-2 expression (40% decrease in UCP-2 mRNA amount in TNF-␣-treated cells compared with control cells, P Ͻ 0.01, n ϭ 3). The TNF-␣-mediated downregulation of UCP-2 mRNA expression remained for the next 12-h treatment (P Ͻ 0.01, n ϭ 3)
Induction of iNOS by TNF-␣. Because the modulatory effect of TNF-␣ on UCP-2 expression was only observed after a 12-h treatment period, we next investigated the potential involvement of intermediary components in the TNF-␣-dependent pathway involved in the control of UCP-2 expression.
Western blot analysis, performed on crude protein extracts obtained from 10 day-differentiated 3T3F442A cells treated for increasing time with 10 ng/ml mouse recombinant TNF-␣ revealed the timedependent appearance of a 130-kDa band identified with the antibody directed against iNOS ( Fig. 2A) . The 130-kDa band was not detectable in control cells at any time point or in cells treated with TNF-␣ for 2-8 h. However, iNOS protein was evidenced after 12 h of TNF-␣ stimulation, and iNOS expression increased during the next 12-h treatment with TNF-␣. In parallel, nitrite determination, performed on cell supernatants, demonstrated a significant accumulation of nitrites after a 12-h stimulation with TNF-␣ (1.8-fold increase in TNF-␣-treated cells compared with untreated cells, P Ͻ 0.05, n ϭ 3; Fig. 2B ). The nitrite accumulation in cell supernatant under TNF-␣ treatment was further enhanced after 24 h (4.8-fold increase in TNF-␣-treated cells compared with untreated cells, P Ͻ 0.01, n ϭ 3), demonstrating the presence of a functional iNOS under TNF-␣ stimulation of 3T3F442A differentiated adipocytes.
To further characterize the direct effect of TNF-␣ on iNOS induction in adipocytes, we studied the TNF-␣ concentration dependency on iNOS induction. Western blot analysis performed on crude protein extracts obtained from 10-day differentiated 3T3F442A cells treated for 24 h with increasing concentrations of TNF-␣ (0.5-50 ng/ml) showed a concentration-dependent induction of iNOS expression. The iNOS protein was detected at a concentration as low as 2.5 ng/ml TNF-␣ and was maximal at the concentration of 20 ng/ml (Fig. 3A) . In parallel, a TNF-␣ concentrationdependent increase in nitrite detected in cell supernatant (Fig. 3B) was observed, further demonstrating that TNF-␣ alone is able to induce iNOS expression in adipocytes. This effect was specific to TNF-␣, since LPS alone did not induce iNOS expression and nitrite accumulation (2.8 Ϯ 0.4 mol/l nitrites in 10 g/ml LPStreated cells vs. 2.5 Ϯ 0.5 mol/l nitrites in control cells) and did not modify the TNF-␣ stimulatory effect (14 Ϯ 2 mol/l nitrites in 10 g/ml LPS together with 10 ng/ml TNF-␣-treated cells vs. 17 Ϯ 3 mol/l nitrites in 10 ng/ml TNF-␣-treated cells). Moreover, preliminary experiments performed with other TNF-␣ sources gave identical results (7.1-fold increase in nitrite accumulation in 10 ng TNF-␣-treated cells vs. control cells, n ϭ 5, P Ͻ 0.01), showing then that TNF-␣ alone is responsible for the iNOS induction.
Involvement of nitric oxide in the TNF-␣-induced downregulation of UCP-2 expression.
To determine whether the TNF-␣-induced iNOS expression and its concomitant nitric oxide (NO) increase was involved in the TNF-␣-mediated downregulation of UCP-2 expression, we analyzed the effect of the specific NOS inhibitor N G -nitro-L-arginine methyl ester (L-NAME) on the TNF-␣-induced decrease of UCP-2 mRNA levels.
L-NAME alone (1 mmol/l) for 12 h did not affect UCP-2 expression, as assessed by Northern blot analysis (Fig. 4A) . However, the downregulation in UCP-2 mRNA amount observed under TNF-␣ treatment was suppressed in the presence of L-NAME (Fig. 4A) . UCP-2 mRNA levels in cells treated for 12 h with both TNF-␣ and L-NAME were not significantly different compared with control cells (n ϭ 3). In parallel, L-NAME led to a complete inhibition of iNOS activity observed under TNF-␣ treatment, since no nitrite accumulation could be detected in supernatants from cells treated for 12 h with TNF-␣ and L-NAME (Fig.  4B) . The effect of L-NAME was specific since its inactive enantiomer D-NAME had no effect on the TNF-␣-induced downregulation of UCP-2 expression (data not shown).
Finally, we studied the effect of an NO donor on UCP-2 expression. Differentiated 3T3F442A adipocytes were treated for 4 h with GSNO at increasing concentrations (0.01, 0.1, and 1 mmol/l). Northern blot analysis revealed that GSNO induced a significant decrease in UCP-2 transcripts in a concentration-dependent manner (Fig. 5) . A 40% decrease in UCP-2 mRNA levels was observed with the concentration of 1 mmol/l compared with untreated cells (P Ͻ 0.05, n ϭ 3). The GSNO-induced downregulation of UCP-2 expression was still present after 12-24 h (data not shown).
DISCUSSION
In the present study, we demonstrate that UCP-2 expression in 3T3F442A differentiated adipocytes is downregulated by TNF-␣ treatment. The further analysis of the TNF-␣ effect on differentiated 3T3F442A adipocytes showed that TNF-␣ treatment alone induced the expression of the iNOS protein in a time-and concentration-dependent manner. Inhibition of iNOS activity led to the suppression of TNF-␣-mediated downregulation of UCP-2 expression, whereas cell treatment with NO donors led to a reduction of UCP-2 Fig. 2 . Effect of TNF-␣ on inducible (i) nitric oxide synthase (NOS) expression and nitrite release. 3T3F442A differentiated adipocytes were treated with TNF-␣ (10 ng/ml) during 2, 8, 12, or 24 h. A: protein extracts were analyzed by Western blot using a specific iNOS antibody. A representative autoradiography of Western blot analysis from 3 independent experiments is shown. Cont, control. B: nitrite (NO 2 ) concentrations in cell supernatant were determined using the Griess reagent. Results are expressed as means Ϯ SE from 3 independent experiments. * P Ͻ 0.05 and ** P Ͻ 0.01 vs. control. Fig. 3 . Effect of TNF-␣ on iNOS expression. Differentiated adipocytes were treated with increasing concentrations of TNF-␣ (0, 0.5, 1, 2.5, 5, 10, 20, or 50 ng/ml). A: protein extracts were analyzed by Western blot using a specific iNOS antibody. A representative autoradiography of Western blot analysis from 3 independent experiments is shown. B: nitrite concentrations were assessed in cell supernatants using the Griess reagent. Results are expressed as means Ϯ SE from 3 independent experiments. ** P Ͻ 0.01 vs. 0 ng/ml TNF-␣. mRNA amounts. Thus an NO-dependent pathway is involved in the TNF-␣-induced downregulation of UCP-2 expression in adipocytes.
UCP-2 belongs to the family of uncoupling proteins recently characterized by the identification and cloning of distinct genes that share homology in their sequences and organization (11, 29) . UCP-2 expression has been found in most tissues. However, UCP-2 roles and functions are still not well defined. UCP-2 has been described to uncouple the mitochondrial respiration (11, 14) and thereby might represent a cellular sensor to monitor the efficiency of the system responsible for supplying energy to the cells. Indeed, a positive correlation was found between the resting metabolic rate (minimal energy expenditure required to maintain physiological tissue function) and UCP-2 expression in obese women, suggesting a potential involvement of UCP-2 in the control of energy expenditure (2). Moreover, because its expression has been demonstrated to be modulated in WAT and liver of obese mice, it appears that UCP-2 expression is dependent on metabolic changes (23) .
Obesity, characterized by an imbalance between energy intake and energy expenditure, is associated with enhanced production and secretion by adipocytes of various cytokines and growth factors, such as leptin and TNF-␣ (20, 25) . Both have been involved in the control of UCP-2 expression. Leptin cDNA transfected in rats by the use of adenovirus has been shown to be associated with an increased UCP-2 expression in the WAT (32), whereas direct leptin administration in mice led to a downregulation of UCP-2 expression (7). Concerning the effect of TNF-␣ on UCP-2 expression, hepatocyte, muscular, and adipocyte UCP-2 trancripts have been shown to be increased under TNF-␣ administration in rats or mice (5, 8, 21, 22) , whereas in human adipocytes maintained in survival, TNF-␣ treatment was reported to lead to a decrease in UCP-2 mRNA levels (30) . Those conflicting data might be explained by the broad interactions with other TNF-␣-dependent pathways when administrating the cytokine "in vivo" compared with direct "in vitro" studies.
In the present report, we demonstrate that, in differentiated 3T3F442A adipocytes, TNF-␣ treatment led to a downregulation of UCP-2 expression, as assessed by Northern blot analysis, since a reliable specific antibody is not still available to perform Western blot analysis.
The TNF-␣-mediated downregulation of UCP-2 transcripts takes place within 12-24 h. The cytokine-induced sustained effects on gene expression are generally mediated through the production of intermediary components. TNF-␣ is known in various cell types to increase the production of reactive radicals (10) . Indeed, reactive oxygen species (hydrogen peroxide and superoxide anions) have been described to act as second messengers in TNF-␣-mediated regulation of various genes. For example, in rat hepatocytes, reactive oxygen species have been involved in the TNF-␣-induced upregulation of UCP-2 transcripts (21). Another highly reactive radical, NO, can also be produced under TNF-␣ stimulation, through iNOS induction (19) . We demonstrate, by the use of Western blot analysis and nitrite determination, that TNF-␣ stimulation of 3T3F442A differentiated adipocytes is associated with an induction of iNOS expression and activity. The presence of iNOS has already been described in WAT from LPS-treated rats (27) and in vivo in human WAT (1) . Moreover, experiments performed in vitro on the preadipocyte cell line 3T3-L1 have recently demonstrated that iNOS expression is induced under treatment with a combination of various cytokines (IFN-␥, TNF-␣, and LPS; see Ref. 17) . We report here that, in the 3T3F442A preadipocyte cell line, TNF-␣ alone induces the iNOS protein and activity. Moreover, the presence of LPS or other cytokines (IFN-␥ and interleukin-␤) together with TNF-␣ does not modify the TNF-␣ stimulatory effect on iNOS induction (A. Bouloumié, personal communication). This discrepancy between both cell lines is not explained and requires further investigations. However, because the 3T3F442A cell line is considered in a more advanced differentiation stage compared with the 3T3-L1 cell line, i.e., it requires only insulin addition for differentiation, whereas corticoids, insulin, together with phosphodiesterase inhibitors are needed for 3T3-L1 cells to differentiate, it can be hypothesized that the 3T3F442A cell line already expresses all the cellular components necessary for the TNF-␣-dependent signaling.
The appearance of iNOS protein and nitrite in the cell supernatants coincides with the second phase of TNF-␣-mediated downregulation of UCP-2 expression. Furthermore, the inhibition of iNOS activity in the presence of the NOS inhibitor L-NAME led to an abolition of the 12-h TNF-␣ effect on UCP-2 expression. All of those results support the hypothesis that iNOS activity is involved in the long-term effect of TNF-␣ on UCP-2 expression. To clearly state the role of the iNOS product NO on the control of UCP-2 expression, cells were treated with the NO donor GSNO. A downregulation of UCP-2 transcript amounts was observed in the presence of the donor, further demonstrating the involvement of NO in the TNF-␣-mediated decrease of UCP-2 expression. The role of NO in adipocytes is not known. Few reports have involved this radical production in the control of lipolysis (13) . The present report demonstrates a direct effect of NO on the control of gene expression. The characterization of the molecular pathway responsible for the NO-mediated decrease of adipocyte UCP-2 expression remains to be established. On other cell types, NO has been involved in the modulation of various intracellular transduction pathways, including modulation regulation of activator protein (AP)-1 and nuclear factor-B DNA-binding activities (9) . The analysis of the murine UCP-2 promoter regions has revealed several AP-1 binding sites and cAMP-response elements that might be potential targets for the NO-mediated effect on UCP-2 expression in adipocytes (31) .
In conclusion, the present study demonstrates that TNF-␣ decreases UCP-2 expression in 3T3F442A adipocytes. NO-dependent pathways are involved in the sustained effect of TNF-␣ on UCP-2 transcripts. Although further analyses are required to characterize this effect and to demonstrate its occurrence in vivo, it is tempting to speculate that the increased production of adipocyte TNF-␣ observed during obesity (16, 18) might play a role in the reduction of adipocyte UCP-2 expression and thus contributes to the metabolic imbalance. In addition, the involvement of NO-dependent pathways in the control of gene expression in adipocytes opens new fields of investigations concerning the effect of such radical production on adipocyte metabolism.
